Interaction between activated ECs and pericytes/vascular smooth-muscle cells (vSMCs) and their targeted inhibitors in red
Schematic of interaction between activated ECs and pericytes/vascular smooth-muscle cells (vSMCs) and their targeted inhibitors in red. PDGFB secreted from the EC binds to its receptor on the mural cell, causing activation of both P13K/AKT/mTOR and RAS/RAF/ERK pathways. Activated ECs have greater ANGPT2 expression, which in the presence of ANGPT1 will inhibit TIE2 receptors, causing enhanced vascular permeability. Altogether, there is decreased pericyte recruitment, enhanced MMP activation, and reduced vascular stability in this interaction
Publication
Defining the Role of Oral Pathway Inhibitors as Targeted Therapeutics in Arteriovenous Malformation Care (2024) Ann Mansur, et al. Biomedicines. 2024 Jun;12(6). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TGFB | TGFB | ncbigene_synonym | TGFB1 | 7040 |
| Homo sapiens | Primates | TGFB | TGFB | famplex_relations | TGFB2 | 7042 |
| Homo sapiens | Primates | TGFB | TGFB | famplex_relations | TGFB3 | 7043 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP1 | 649 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP2 | 650 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP3 | 651 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP4 | 652 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP5 | 653 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP6 | 654 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP7 | 655 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP8A | 353500 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP8B | 656 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP10 | 27302 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | BMP15 | 9210 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | GDF1 | 2657 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | GDF2 | 2658 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | GDF3 | 9573 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | GDF5 | 8200 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | GDF6 | 392255 |
| Homo sapiens | Primates | BMP | BMP | famplex_relations | GDF7 | 151449 |
| Homo sapiens | Primates | ALK5 | ALK5 | ncbigene_synonym | TGFBR1 | 7046 |
| Homo sapiens | Primates | Eng | ENG | ncbigene_symbol | ENG | 2022 |
| Homo sapiens | Primates | Alk1 | ALK1 | ncbigene_synonym | ACVRL1 | 94 |
| Homo sapiens | Primates | Alk1 | ALK1 | ncbigene_synonym | ALK | 238 |
| Homo sapiens | Primates | Alk1 | ALK1 | ncbigene_synonym | SLPI | 6590 |
| Homo sapiens | Primates | MTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | VEGFA | VEGFA | ncbigene_symbol | VEGFA | 7422 |
| Homo sapiens | Primates | EGF | EGF | ncbigene_symbol | EGF | 1950 |
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | SMAD | SMAD | famplex_relations | SMAD1 | 4086 |
| Homo sapiens | Primates | SMAD | SMAD | famplex_relations | SMAD4 | 4089 |
| Homo sapiens | Primates | SMAD | SMAD | famplex_relations | SMAD5 | 4090 |
| Homo sapiens | Primates | SMAD | SMAD | famplex_relations | SMAD6 | 4091 |
| Homo sapiens | Primates | SMAD | SMAD | famplex_relations | SMAD7 | 4092 |
| Homo sapiens | Primates | SMAD | SMAD | famplex_relations | SMAD9 | 4093 |
| Homo sapiens | Primates | SMAD | SMAD | famplex_relations | SMAD2 | 4087 |
| Homo sapiens | Primates | SMAD | SMAD | famplex_relations | SMAD3 | 4088 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | RAF | RAF | ncbigene_synonym | ZHX2 | 22882 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | ARAF | 369 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | BRAF | 673 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | RAF1 | 5894 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | ERK | ERK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | MEK | MEK | ncbigene_synonym | MAP2K7 | 5609 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K2 | 5605 |
| Homo sapiens | Primates | PDGFB | PDGFB | ncbigene_symbol | PDGFB | 5155 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| BMP | BMP | chebi:60815 | ||
| Thalidomide | thalidomide | rac-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione | chebi:9513 | |
| inhibitors | inhibitors | inhibitor | chebi:35222 | |
| Sirolimus | sirolimus | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone | chebi:9168 | |
| EGF | EGF | L-alpha-glutamylglycyl-L-phenylalanine | chebi:140739 | |
| Pazopanib | pazopanib | 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide | chebi:71219 | |
| RAS | RAS | (1R)-N-(prop-2-yn-1-yl)indan-1-amine | chebi:63620 | |
| Sotorasib | sotorasib | 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one | chebi:178199 | |
| MEK | MEK | butan-2-one | chebi:28398 | |
| Trametinib | trametinib | N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide | chebi:75998 | |
| MEK | MEK | butan-2-one | chebi:28398 | |
| Trametinib | trametinib | N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide | chebi:75998 | |
| Sunitinib | sunitinib | N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide | chebi:38940 | |
| Ponatinib | ponatinib | 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide | chebi:78543 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|